There is evidence that nutritional impairment can complicate juvenile idiopathic arthritis
(JIA). It is also recognized that the JIA drug treatment may affect the nutritional aspects of …

Background The association between diet, symptoms and health related quality of life in
children and young people with Juvenile idiopathic arthritis (JIA) is not clearly understood …

Background The etiology of juvenile idiopathic arthritis (JIA) is poorly understood. This study
investigated genetic and environmental factors and infant gut microbiota in a prospective …

Background Currently, the association between the consumption of polyunsaturated fatty
acids (PUFAs) and the susceptibility to autoimmune rheumatic diseases (ARDs) remains …

Methotrexate (MTX) is a chemotherapeutic agent used for cancer and autoimmune
disorders. MTX may cause multi-organ affections. However, few studies examined MTX …

Juvenile idiopathic arthritis (JIA) represents a chronic, autoimmune, rheumatic
musculoskeletal disease with a diagnosis before 16 years of age. Chronic arthritis is a …

Eating habits have been analysed for years as a factor influencing the development of
autoimmune diseases and susceptibility to infections. On the basis of research …

Although most rheumatic disease outcomes are improving, cardiovascular disease (CVD)
remains a leading cause of mortality in adults with systemic lupus erythematosus …

Variability in methotrexate (MTX) efficacy represents a barrier to early and effective disease
control in the treatment of juvenile idiopathic arthritis (JIA). This work seeks to understand …

Aim of the work To assess the effect of vitamin D receptor (VDR) polymorphism on lipid
profile in patients with juvenile idiopathic arthritis (JIA) and study its relation to disease …